Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression

This study has been terminated.
(Closed due to low enrollment)
Sponsor:
Collaborators:
Case Western Reserve University
Bristol-Myers Squibb
Information provided by (Responsible Party):
Marisa Tungsiripat, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT01194856
First received: September 2, 2010
Last updated: February 28, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)